Biochemistry: New study shows why swine flu virus develops drug resistance

June 2012
Biomedical Market Newsletter;6/1/2012, Vol. 21, p1
The article offers information on a study which shows mechanism used by swine flu virus to resist action of anti flu drugs.


Related Articles

  • CDC reports multiple cases of oseltamivir-resistant influenza A H1N1.  // Infectious Diseases in Children;Oct2009, Vol. 22 Issue 10, p34 

    The article focuses on the cases of oseltamivir-resistant influenza A H1N1 reported by the U.S. Centers for Disease Control and Prevention (CDC).

  • Oseltamivir/peramivir.  // Reactions Weekly;7/10/2010, Issue 1309, p31 

    The article describes the case of two immunocompromised patients who acquired influenza A H1N1 infections resistant to oseltamivir and peramivir.

  • Oseltamivir.  // Reactions Weekly;11/13/2010, Issue 1327, p28 

    The article describes two cases of intratreatment resistance to oseltamivir in pandemic influenza A H1N1 virus infection of a two-year-old boy and a one-year-old girl.

  • Oseltamivir.  // Reactions Weekly;7/24/2010, Issue 1311, p33 

    The article describes the case of an infant girl who developed resistance to oseltamivir during treatment for 2009 H1N1 influenza A virus.

  • H1N1 Has Yet to Finish Its Run.  // USA Today Magazine;Apr2010, Vol. 138 Issue 2779, p15 

    The article discusses findings of a study funded by the U.S. Army Research Laboratory and Office in Adelpi, Maryland which revealed the possibility that most strains of the pandemic H1N1 influenza virus will become resistant to Tamiflu, the main drug stockpiled for use against it.

  • 2009H1N1 Influenza in Immunocompetent and Immunocompromised Patients. Moss, Ronald B. // Infectious Diseases: Research & Treatment;2012, Issue 5, p33 

    The treatment and prevention of influenza virus infection has been associated with two major challenges that are exemplified by 2009H1N1 as well as previous pandemics. The constant evolutionary pressure on the influenza virus can result in novel strains which may not be optimally protected by...

  • Global Transmission of Oseltamivir-Resistant Influenza. Moscona, Anne // New England Journal of Medicine;3/5/2009, Vol. 360 Issue 10, p953 

    The author reflects on the global transmission of the oseltamivir-resistant influenza A virus (H1N1), which is also called swine influenza. He suggests that the possibility of widespread oseltamivir resistance has been a concern for several years. He argues that the news about oseltamivir...

  • Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir. Reddy, David // Journal of Antimicrobial Chemotherapy (JAC);Apr2010 Supplement 2, Vol. 65 Issue suppl_2, pii35 

    Pandemic (H1N1) 2009 influenza is affecting countries in all five continents, with most cases so far having been reported in North and South America and Europe, and children and young adults being the most susceptible age groups. To date, the clinical course of disease is typically mild, with...

  • Targeting pandemic influenza: a primer on influenza antivirals and drug resistance. Moss, Ronald B.; Davey, Richard T.; Steigbigel, Roy T.; Fang Fang // Journal of Antimicrobial Chemotherapy (JAC);Jun2010, Vol. 65 Issue 6, p1086 

    The emergence of the 2009 H1N1 pandemic influenza A virus, as well as constant antigenic drift of seasonal influenza, underscores the remarkable versatility of this virus in adapting to the human population. While vaccines are the principal public health defence against influenza, rapid vaccine...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics